Nephros (NEPH) Total Current Liabilities (2010 - 2026)
Nephros (NEPH) posted quarterly Total Current Liabilities of $2.5 million for Q1 2026, up 66.47% year-over-year from $1.5 million in Q1 2025, and down 8.67% quarter-over-quarter from $2.8 million in Q4 2025.
Nephros (NEPH) Total Current Liabilities (2010 - 2026) Analysis & Trends
Nephros' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 66.47% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 66.47% YoY), while the FY2025 annual figure was $2.8 million, up 77.14% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $2.5 million, down from $2.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $2.8 million in Q4 2025, with the low at $1.1 million in Q3 2024.
- The 5-year median for Total Current Liabilities is $1.8 million (2025), against an average of $1.8 million.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities sank 43.3% in 2023, then jumped 133.18% in 2025.
- Nephros' Total Current Liabilities stood at $1.4 million in 2022, then soared by 49.65% to $2.1 million in 2023, then dropped by 26.08% to $1.6 million in 2024, then soared by 77.14% to $2.8 million in 2025, then dropped by 8.67% to $2.5 million in 2026.
- Business Quant data shows NEPH's Total Current Liabilities at $2.5 million in Q1 2026, $2.8 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.89 Bn | 127.67 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.87 Bn | 51.01 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.51 Bn | 34.16 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.52 Bn | 32.06 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 28.31 Bn | 25.63 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.26 Bn | 14.86 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Nephros | 46.14 Mn | 41.44 Mn | 4.03 Mn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.34 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 2.39 Mn |
| Sep 30, 2021 | 1.82 Mn |